← Back to patent-cliff list
CAS 1221157-11-4
methyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate hydrochloride
Codes: BENDAM-009
Application context (from source-drug indications)
B-cell lymphomaBendamustine HydrochlorideNon-Hodgkin lymphomaBendamustine HydrochlorideChronic lymphocytic leukaemiaBendamustine HydrochlorideMantle cell lymphomaBendamustine HydrochlorideLymphomaBendamustine HydrochlorideMultiple myelomaBendamustine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Bendamustine Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,4-dinitroaniline→methyl 5-chloro-5-oxopentanoate→methyl 5-((2,4-dinitrophenyl)amino)-5-oxopentanoate→methyl 5-((2,4-dinitrophenyl)(methyl)amino)-5-oxopentanoate→methyl 4-(5-amino-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate hydrochloride→methyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.